This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examini…

Cystic FibrosisPulmonary FibrosisTuberous Sclerosis+2 more

~Estimated

~$10 – $675

National Heart, Lung, and Blood Institute (NHLBI)NCT00001532

Phase 2

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of a 12-week Administration of OATD-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis (the KITE Study)

This is a Phase 2, randomized, double-blind, placebo-controlled, adaptive, multicenter study to evaluate the efficacy, safety, tolerability, Pharmacodynamics (…

Pulmonary Sarcoidosis

~Estimated

~$10 – $8,750

Molecure S.A.NCT06205121